Breaking News

Almac Expands UK Commercial Capacity

October 3, 2012

Acquires new blistering technology

Almac has expanded its MHRA/FDA-approved UK commercial packaging facility with the acquisition of a Noack N 623 blister packaging line from Romaco. The line accommodates enhanced flexibility for larger blister sizes and multi unit blister formats, coupled with a requirement for non-permeability and enhanced environmental protection.
 
This cGMP-compliant technology can be configured to process both thermoform and coldform materials, with maximum blister sizes of 220mm x 155mm. The Noack N 623 has an automatic feeding system, filling inspection and ejection station and shorter set-up times. It can process more than 25,000 blisters per hour, including multi-product blisters.
 
“Blister size and dosage formats are becoming increasingly more complex. Additionally, product handling for innovative new molecules often requires enhanced environmental controls. This investment allows Almac, through its Pharma Services business unit, to offer this additional flexibility,” said Geoff Sloan vice president of manufacturing operations. “Through this acquisition, coupled with our immanent entry into the U.S. commercial packaging market, we continue to expand our capabilities and flexibility to meet our client’s needs.”

Related Packaging:

Related Contract Manufacturing:

blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.